Search

Your search keyword '"Fischer, Melissa"' showing total 416 results

Search Constraints

Start Over You searched for: Author "Fischer, Melissa" Remove constraint Author: "Fischer, Melissa" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
416 results on '"Fischer, Melissa"'

Search Results

2. Curricular Reform in Serious Illness Communication and Palliative Care: Using Medical Students’ Voices to Guide Change

4. Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation

8. Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies

9. Contributors

11. Maternity Leave Satisfaction Among Physicians Compared with Nonphysician Professionals.

13. DRIVE: Diversity, Representation, and Inclusion for Value in Education – interprofessional faculty development for a bias-free curriculum at UMass Chan Medical School

14. Figure S3 from Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction

16. Supplementary Figures and Table from A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

17. Data from A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia

18. Supplemental data from BET Inhibition Enhances the Antileukemic Activity of Low-dose Venetoclax in Acute Myeloid Leukemia

27. Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction

37. Anatomy of Pelvic Support

39. Discovery and biological characterization of potent myeloid cell leukemia‐1 inhibitors

40. Abstract IA-52: Improving access to research among individuals from under-represented racial and ethnic minority communities: The Strengthening Research In Diverse Enrollment (STRIDE) Study

41. One Head Start Classroom's Experience: Computers and Young Children's Development.

48. The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib

50. HDAC3 is essential for DNA replication in hematopoietic progenitor cells

Catalog

Books, media, physical & digital resources